Total Payments
$41,108
2024 Payments
$4,310
Companies
45
Transactions
1,233
Medicare Patients
15,930
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$33,626 (81.8%)
Consulting$6,200 (15.1%)
Other$700.00 (1.7%)
Education$574.31 (1.4%)
Travel$8.38 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $33,626 | 1,217 | 81.8% |
| Consulting Fee | $6,200 | 2 | 15.1% |
| Honoraria | $700.00 | 2 | 1.7% |
| Education | $574.31 | 9 | 1.4% |
| Travel and Lodging | $8.38 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $8,456 | 125 | $0 (2024) |
| ABBVIE INC. | $5,968 | 177 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $3,624 | 118 | $0 (2024) |
| GENZYME CORPORATION | $2,602 | 89 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $2,388 | 103 | $0 (2024) |
| Lilly USA, LLC | $2,122 | 65 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,515 | 60 | $0 (2024) |
| Amgen Inc. | $1,407 | 52 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $1,280 | 54 | $0 (2024) |
| Biofrontera Inc. | $1,171 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,310 | 143 | GENZYME CORPORATION ($865.60) |
| 2023 | $4,183 | 159 | Sun Pharmaceutical Industries Inc. ($579.35) |
| 2022 | $4,761 | 185 | ABBVIE INC. ($1,121) |
| 2021 | $3,572 | 172 | AbbVie Inc. ($550.36) |
| 2020 | $2,773 | 121 | AbbVie Inc. ($466.11) |
| 2019 | $4,809 | 163 | AbbVie, Inc. ($1,016) |
| 2018 | $8,245 | 157 | Janssen Biotech, Inc. ($3,783) |
| 2017 | $8,455 | 133 | Janssen Biotech, Inc. ($3,460) |
All Payment Transactions
1,233 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.39 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $146.48 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $36.24 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: DERMATOLOGY | ||||||
| 11/29/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Immunology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.48 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $40.72 | General |
| Category: Immunology | ||||||
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $35.61 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $111.58 | General |
| 11/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $3.81 | General |
| Category: Immunology | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.51 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $46.32 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,559 | 6,594 | $1.2M | $250,675 |
| 2022 | 23 | 3,988 | 6,721 | $858,305 | $278,920 |
| 2021 | 26 | 4,201 | 6,940 | $687,615 | $321,535 |
| 2020 | 23 | 4,182 | 6,661 | $661,064 | $259,326 |
Total Patients
15,930
Total Services
26,916
Medicare Billing
$1.1M
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 913 | 1,416 | $377,639 | $83,497 | 22.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 520 | 649 | $195,715 | $41,891 | 21.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 595 | 853 | $169,650 | $30,888 | 18.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 291 | 341 | $115,173 | $26,306 | 22.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 447 | 2,402 | $47,621 | $11,707 | 24.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 156 | 156 | $51,566 | $10,682 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 112 | $42,312 | $10,052 | 23.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 138 | 174 | $25,949 | $6,541 | 25.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 23 | 24 | $21,775 | $5,188 | 23.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 111 | 116 | $19,422 | $4,402 | 22.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 32 | 37 | $18,400 | $4,311 | 23.4% |
| 69100 | Biopsy of ear | Office | 2023 | 47 | 52 | $14,882 | $2,771 | 18.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 18 | $9,572 | $2,225 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $8,857 | $2,184 | 24.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 44 | 44 | $9,442 | $2,096 | 22.2% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 20 | $10,179 | $2,002 | 19.7% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 18 | 18 | $6,694 | $1,557 | 23.3% |
| 10040 | Acne surgery | Office | 2023 | 12 | 12 | $4,176 | $1,066 | 25.5% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 14 | 14 | $6,067 | $964.49 | 15.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 28 | $1,175 | $276.07 | 23.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 90 | $1,830 | $67.42 | 3.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,118 | 1,650 | $272,422 | $94,287 | 34.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 567 | 697 | $140,315 | $46,611 | 33.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 695 | 918 | $130,366 | $35,564 | 27.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 232 | 249 | $63,615 | $19,888 | 31.3% |
About Dr. Boris Ioffe, D.O
Dr. Boris Ioffe, D.O is a Dermatology healthcare provider based in Duncanville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1598949646.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Boris Ioffe, D.O has received a total of $41,108 in payments from pharmaceutical and medical device companies, with $4,310 received in 2024. These payments were reported across 1,233 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($33,626).
As a Medicare-enrolled provider, Ioffe has provided services to 15,930 Medicare beneficiaries, totaling 26,916 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Duncanville, TX
- Active Since 12/26/2007
- Last Updated 12/26/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1598949646
Products in Payments
- Tremfya (Drug) $4,024
- DUPIXENT (Biological) $3,027
- COSENTYX (Biological) $2,833
- Humira (Biological) $2,150
- Otezla (Drug) $1,837
- SKYRIZI (Biological) $1,278
- RINVOQ (Biological) $1,187
- TALTZ (Drug) $1,187
- EUCRISA (Drug) $1,034
- Ameluz (Drug) $1,000
- ILUMYA (Biological) $942.14
- Sotyktu (Drug) $780.70
- TREMFYA (Drug) $725.13
- Cimzia (Drug) $716.27
- COSENTYX (Drug) $693.24
- STELARA (Biological) $613.48
- Enbrel (Biological) $502.29
- DUOBRII (Drug) $467.45
- OPZELURA (Drug) $461.86
- DUPIXENT (Drug) $443.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.